Financials
- Market Capitalization 21.57 M
- Employee 24
- Founded 2005
- CEO Sabrina Martucci Johnson
- Website www.darebioscience.com
- Headquarter Delaware, United States
- FIGI BBG001J2P362
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2
売上高対価格比率
18.23
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4532 | RADX Radiopharm Theranostics Limited American Depositary Shares | 2.86 USD | +2.14% | -0.69% | -32.71% | -46.34% | 22.55 M USD | ||
| 4533 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.88 USD | -0.50% | +13.31% | +1.76% | +137.26% | 22.47 M USD | ||
| 4545 | LGVN Longeveron Inc. - Class A Common stock | 0.69 USD | -6.76% | -6.76% | 0.00% | +20.78% | 21.49 M USD | ||
| 4551 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.65 USD | +1.92% | -0.38% | -5.69% | -15.61% | 21.18 M USD |